Switch to:
Also traded in: Brazil, Chile, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.04
CVS's Cash to Debt is ranked lower than
100% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.97 vs. CVS: 0.04 )
Ranked among companies with meaningful Cash to Debt only.
CVS' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.14 Max: 1.14
Current: 0.04
0.04
1.14
Equity to Asset 0.38
CVS's Equity to Asset is ranked higher than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. CVS: 0.38 )
Ranked among companies with meaningful Equity to Asset only.
CVS' s Equity to Asset Range Over the Past 10 Years
Min: 0.38  Med: 0.54 Max: 0.67
Current: 0.38
0.38
0.67
Interest Coverage 8.54
CVS's Interest Coverage is ranked lower than
67% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.13 vs. CVS: 8.54 )
Ranked among companies with meaningful Interest Coverage only.
CVS' s Interest Coverage Range Over the Past 10 Years
Min: 8.54  Med: 11.43 Max: 15.55
Current: 8.54
8.54
15.55
F-Score: 5
Z-Score: 3.78
M-Score: -2.53
WACC vs ROIC
7.22%
9.79%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 5.75
CVS's Operating margin (%) is ranked higher than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.72 vs. CVS: 5.75 )
Ranked among companies with meaningful Operating margin (%) only.
CVS' s Operating margin (%) Range Over the Past 10 Years
Min: 5.57  Med: 6.3 Max: 6.91
Current: 5.75
5.57
6.91
Net-margin (%) 2.89
CVS's Net-margin (%) is ranked higher than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.76 vs. CVS: 2.89 )
Ranked among companies with meaningful Net-margin (%) only.
CVS' s Net-margin (%) Range Over the Past 10 Years
Min: 2.89  Med: 3.44 Max: 3.76
Current: 2.89
2.89
3.76
ROE (%) 13.18
CVS's ROE (%) is ranked higher than
64% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.14 vs. CVS: 13.18 )
Ranked among companies with meaningful ROE (%) only.
CVS' s ROE (%) Range Over the Past 10 Years
Min: 9.14  Med: 11.33 Max: 14.85
Current: 13.18
9.14
14.85
ROA (%) 5.40
CVS's ROA (%) is ranked higher than
77% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.46 vs. CVS: 5.40 )
Ranked among companies with meaningful ROA (%) only.
CVS' s ROA (%) Range Over the Past 10 Years
Min: 5.4  Med: 6.14 Max: 7.64
Current: 5.4
5.4
7.64
ROC (Joel Greenblatt) (%) 59.74
CVS's ROC (Joel Greenblatt) (%) is ranked lower than
59% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 117.64 vs. CVS: 59.74 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CVS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 26.8  Med: 47.33 Max: 62.63
Current: 59.74
26.8
62.63
Revenue Growth (3Y)(%) 12.30
CVS's Revenue Growth (3Y)(%) is ranked lower than
54% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.70 vs. CVS: 12.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CVS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 7.7  Med: 12.3 Max: 16
Current: 12.3
7.7
16
EBITDA Growth (3Y)(%) 15.10
CVS's EBITDA Growth (3Y)(%) is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.50 vs. CVS: 15.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CVS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.5  Med: 14.2 Max: 43.7
Current: 15.1
2.5
43.7
EPS Growth (3Y)(%) 15.20
CVS's EPS Growth (3Y)(%) is ranked higher than
60% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.70 vs. CVS: 15.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CVS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 1.7  Med: 15.2 Max: 112.8
Current: 15.2
1.7
112.8
» CVS's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-10-30)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

CVS Guru Trades in Q3 2015

John Burbank 30,304 sh (New)
Mairs and Power 2,246 sh (New)
Jim Simons 854,505 sh (New)
Louis Moore Bacon 123,000 sh (+146.00%)
Jeremy Grantham 2,397,897 sh (+16.47%)
RS Investment Management 714,365 sh (+4.84%)
Richard Pzena 527,265 sh (unchged)
Tom Gayner 247,000 sh (unchged)
Ruane Cunniff 24,953 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Steven Cohen Sold Out
John Rogers Sold Out
Barrow, Hanley, Mewhinney & Strauss 383,650 sh (-1.62%)
Manning & Napier Advisors, Inc 85,900 sh (-2.64%)
Signature Select Canadian Fund 72,453 sh (-4.36%)
NWQ Managers 783,473 sh (-4.44%)
PRIMECAP Management 3,408,820 sh (-5.38%)
Charles de Vaulx 840,664 sh (-8.21%)
Scott Black 89,505 sh (-10.01%)
Mario Gabelli 1,215,593 sh (-10.62%)
Pioneer Investments 4,893,987 sh (-10.86%)
Paul Tudor Jones 2,600 sh (-18.75%)
Vanguard Health Care Fund 3,084,020 sh (-20.92%)
Robert Olstein 45,000 sh (-21.05%)
Ken Fisher 122,805 sh (-21.50%)
Jeff Auxier 52,499 sh (-45.11%)
Joel Greenblatt 20,797 sh (-77.20%)
First Pacific Advisors 681,570 sh (-85.25%)
Steven Romick 507,110 sh (-87.77%)
» More
Q4 2015

CVS Guru Trades in Q4 2015

George Soros 25,971 sh (New)
Ray Dalio 83,137 sh (New)
Paul Tudor Jones 8,633 sh (+232.04%)
Mairs and Power 3,819 sh (+70.04%)
Robert Olstein 64,000 sh (+42.22%)
RS Investment Management 788,185 sh (+10.33%)
PRIMECAP Management 3,545,070 sh (+4.00%)
Pioneer Investments 5,082,510 sh (+3.85%)
Manning & Napier Advisors, Inc 86,300 sh (+0.47%)
Richard Pzena 527,389 sh (+0.02%)
Jeff Auxier 52,499 sh (unchged)
Vanguard Health Care Fund 3,084,020 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Charles de Vaulx 840,664 sh (unchged)
Tom Gayner 247,000 sh (unchged)
Steven Romick Sold Out
Joel Greenblatt Sold Out
Louis Moore Bacon Sold Out
Jim Simons Sold Out
John Burbank Sold Out
Ken Fisher 122,308 sh (-0.40%)
NWQ Managers 760,638 sh (-2.91%)
Mario Gabelli 1,178,788 sh (-3.03%)
Barrow, Hanley, Mewhinney & Strauss 368,897 sh (-3.85%)
Jeremy Grantham 2,300,997 sh (-4.04%)
Ruane Cunniff 18,153 sh (-27.25%)
Scott Black 19,044 sh (-78.72%)
First Pacific Advisors 127,300 sh (-81.32%)
» More
Q1 2016

CVS Guru Trades in Q1 2016

Steven Cohen 115,300 sh (New)
Murray Stahl 3,090 sh (New)
Dodge & Cox 2,630 sh (New)
Jim Simons 195,105 sh (New)
Joel Greenblatt 220,252 sh (New)
Ken Fisher 142,324 sh (+16.37%)
George Soros 27,511 sh (+5.93%)
Pioneer Investments 5,363,313 sh (+5.52%)
Manning & Napier Advisors, Inc 87,090 sh (+0.92%)
Mario Gabelli 1,188,900 sh (+0.86%)
Jeremy Grantham 2,319,096 sh (+0.79%)
RS Investment Management 792,755 sh (+0.58%)
Richard Pzena 528,659 sh (+0.24%)
PRIMECAP Management 3,548,780 sh (+0.10%)
Robert Olstein 64,000 sh (unchged)
Tom Gayner 247,000 sh (unchged)
Paul Tudor Jones 50,200 sh (unchged)
Paul Tudor Jones 47,500 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Paul Tudor Jones Sold Out
Vanguard Health Care Fund Sold Out
Ray Dalio Sold Out
Barrow, Hanley, Mewhinney & Strauss Sold Out
Jeff Auxier 52,349 sh (-0.29%)
Signature Select Canadian Fund 70,053 sh (-3.31%)
Scott Black 18,149 sh (-4.70%)
NWQ Managers 707,549 sh (-6.98%)
Charles de Vaulx 778,764 sh (-7.36%)
Ruane Cunniff 15,981 sh (-11.96%)
First Pacific Advisors 106,140 sh (-16.62%)
Mairs and Power 3,069 sh (-19.64%)
» More
Q2 2016

CVS Guru Trades in Q2 2016

Louis Moore Bacon 2,679 sh (New)
Ray Dalio 149,700 sh (New)
Paul Tudor Jones 33,167 sh (New)
Jerome Dodson 234,000 sh (New)
John Buckingham 43,573 sh (New)
Jim Simons 3,842,105 sh (+1869.25%)
Joel Greenblatt 652,002 sh (+196.03%)
George Soros 41,175 sh (+49.67%)
Robert Olstein 91,000 sh (+42.19%)
RS Investment Management 897,935 sh (+13.27%)
Murray Stahl 3,397 sh (+9.94%)
First Pacific Advisors 114,190 sh (+7.58%)
Pioneer Investments 5,751,921 sh (+7.25%)
Richard Pzena 529,884 sh (+0.23%)
Jeff Auxier 52,349 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Tom Gayner 247,000 sh (unchged)
Mairs and Power 3,069 sh (unchged)
Steven Cohen Sold Out
Dodge & Cox Sold Out
PRIMECAP Management 3,527,170 sh (-0.61%)
Manning & Napier Advisors, Inc 86,530 sh (-0.64%)
Mario Gabelli 1,139,978 sh (-4.11%)
Scott Black 17,206 sh (-5.20%)
Ruane Cunniff 14,856 sh (-7.04%)
Ken Fisher 129,783 sh (-8.81%)
NWQ Managers 607,584 sh (-14.13%)
Jeremy Grantham 1,825,963 sh (-21.26%)
» More
» Details

Insider Trades

Latest Guru Trades with CVS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:NYSE:UNH, NAS:ESRX, NYSE:AET, NYSE:CI, NYSE:HUM, NYSE:CNC, NYSE:ANTX, NYSE:HNT, NYSE:WCG, NYSE:MOH, NAS:MGLN, NYSE:UAM, NAS:HIIQ, OTCPK:QULRY, NAS:CNXR, OTCPK:OPRX, OTCPK:WCUI » details
Traded in other countries:CVSH34.Brazil, CVS.Chile, CVS.Germany, CVS.Mexico,
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

CVS Health Corp, formerly known as CVS Caremark Corporation was incorporated in the State of Delaware. The Company is an integrated pharmacy health care provider in the United States. It has three segments: Pharmacy Services, Retail Pharmacy and Corporate. The pharmacy services segment provides pharmacy benefit management services to their clients consisting of employers, insurance companies, unions, government employee groups, managed care organizations ("MCOs") and other sponsors of health benefit plans and individuals throughout the United States. The Company operates a network of mail service specialty pharmacies. There specialty pharmacies were comprised of 11 specialty mail order pharmacies located throughout the United States that are used for delivery of medications to individuals with chronic or genetic diseases and disorders. The retail pharmacy segment included 7,660 retail drugstores, of which 7,603 operated a pharmacy, their online retail pharmacy websites, CVS.com and Onofre.com.br, 17 onsite pharmacy stores and retail health care clinics. There corporate segment provides management and administrative services to support the operations of the company. The corporate Segment consists of certain aspects of executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments. Its customers include managed care organizations and government-funded health care commercial employers. It competes with other drugstore chains like Walgreens and Rite Aid, supermarkets, discount retailers (e.g., Wal-Mart and Target), independent pharmacies, restrictive pharmacy networks, membership clubs, Internet companies and retail health clinics, as well as other mail order pharmacies and PBMs. The Company's business is subject to federal and state laws and regulations that govern the purchase, sale and distribution of prescription drugs and related services, including administration and management of prescription drug benefits.

Guru Investment Theses on CVS Health Corp

Mario Gabelli Comments on CVS Health Corp - Feb 05, 2016

CVS Health Corp. (2.4%) (CVS – $97.77 – NYSE)(NYSE:CVS) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The company’s recent acquisitions of institutional pharmacy Omnicare and the pharmacies inside Target stores should add $0.15 to earnings in 2016 and further CVS’s dominance across the pharmacy channel. Same store sales should improve in 2016 now that the company has annualized its decision to stop selling tobacco, and that decision has helped them win over $11 billion in net new business for its pharmacy benefits management (PBM) division.

From Mario Gabelli (Trades, Portfolio)'s GAMCO Equity Income Fund fourth quarter 2015 commentary.

Check out Mario Gabelli latest stock trades

Mario Gabelli Comments on CVS Health Corp - Mar 12, 2015

CVS Health Corp. (0.9%) (CVS – $96.31 – NYSE) is a pharmacy innovation company helping people on their path to better health. Through their 7,800 retail pharmacies, more than 900 walk-in medical clinics, a leading pharmacy benefits manager with nearly 65 million plan members, and expanding specialty pharmacy services, CVS Health enables people, businesses and communities to manage health in more affordable, effective ways. Their unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.

From Mario Gabelli (Trades, Portfolio)’s Asset Fund Q4 2014 Commentary.

Check out Mario Gabelli latest stock trades

Mario Gabelli Comments on CVS Health Corp - Oct 29, 2014

CVS Health Corp. (1.6%) (CVS - $79.59 - NYSE) operates one of the largest retail pharmacy chains in the country, and the company is poised to benefit from the expansion of insurance coverage under healthcare reform with no new taxes or regulation. CVS is expanding into the fast growing market for specialty and biotech medicines, particularly through the recently announced $2 billion acquisition of home infusion provider Coram. CVS Health recently stopped selling tobacco in its stores, but the company is performing so strongly this year that it can easily absorb the $2 billion in lost sales. The company can sustain double digit earnings growth, and management continues to return a substantial amount of cash to shareholders via a higher dividend and share repurchases.

From Mario Gabelli (Trades, Portfolio)’s Equity Income Fund Q3 2014 Commentary.

Check out Mario Gabelli latest stock trades

Top Ranked Articles about CVS Health Corp

Ray Dalio's 5 Biggest 2nd-Quarter New Stock Buys Dalio bought Johnson & Johnson, CVS and more
Ray Dalio (Trades, Portfolio) manages the $150 billion Westport, Connecticut-based hedge fund Bridgewater Associates, the largest hedge fund firm in the world. The equity portfolio at Bridgewater has a total value of only $7.98 billion. According to filings disclosed Thursday, Dalio added 139 new positions to it in the second quarter. Read more...
Jerome Dodson Goes 3 for 3 in Second Quarter Dodson gains 3 new holdings, sells 3
Investor Jerome Dodson (Trades, Portfolio) of the Parnassus Fund gained three new holdings and sold out three holdings during the second quarter. Read more...
Stocks Manning & Napier Continues Buying Firm has been investing in these companies for the last 2 quarters
Manning & Napier Advisors Inc. was founded in April 1970 by Bill Manning and Bill Napier. It manages a portfolio composed of 325 stocks, several of which have been bought for the last two quarters. Read more...
Pioneer Investments Adds to Stake in CVS Company has 53 years of experience with over $150 billion in annual revenue
Pioneer Investments (Trades, Portfolio) was founded by Philip L. Carret in 1928. Carret started his own investment portfolio with $10,000. Over the course of the next 55 years, his initial investment grew to $8 million. Warren Buffett (Trades, Portfolio) once said that Carret had "the best long term investment record of anyone I know." Read more...
High Quality Guru Stocks Include TransDigm, Chipotle Stocks with high business predictability that gurus are buying
According to GuruFocus’ All-in-One Screener, the following stocks have a high business predictability rating and at least five gurus are shareholders in the companies. Read more...
Louis Moore Bacon Sells JPMorgan, Pfizer The guru's largest 4th-quarter transactions
Louis Moore Bacon (Trades, Portfolio) is an American hedge fund manager and trader who uses a global macro strategy to invest in the markets. Bacon has been in the top 20 of Top 100 money earners since the 1990s. He is considered one of the top 100 traders of the 20th century, and the following are his most heavily weighted trades during the fourth quarter of 2015. Read more...
Mario Gabelli Comments on CVS Health Corp Guru stock highlight
CVS Health Corp. (2.4%) (CVS – $97.77 – NYSE)(NYSE:CVS) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The company’s recent acquisitions of institutional pharmacy Omnicare and the pharmacies inside Target stores should add $0.15 to earnings in 2016 and further CVS’s dominance across the pharmacy channel. Same store sales should improve in 2016 now that the company has annualized its decision to stop selling tobacco, and that decision has helped them win over $11 billion in net new business for its pharmacy benefits management (PBM) division. Read more...
Steven Romick Sells Microsoft, Walgreens, CVS FPA portfolio manager trims Microsoft stake by 20%
Steven Romick (Trades, Portfolio) sold many stocks during the fourth quarter. He is the portfolio manager of the FPA Crescent Fund and the following are the most weighted sales during the last quarter of 2015. Read more...
First Pacific Advisors Slashes Stake in CVS Health Guru nearly triples stake in United Technologies, invests in stake in Esterline Technologies
First Pacific Advisors (Trades, Portfolio), a Los Angeles-based investment management firm, has a preference for stocks in the technology and financial services sectors, but its most eye-popping deal in the third quarter was the reduction of a stake in the health care sector. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 22.37
CVS's P/E(ttm) is ranked lower than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.80 vs. CVS: 22.37 )
Ranked among companies with meaningful P/E(ttm) only.
CVS' s P/E(ttm) Range Over the Past 10 Years
Min: 10.58  Med: 18.44 Max: 27.17
Current: 22.37
10.58
27.17
Forward P/E 16.81
CVS's Forward P/E is ranked lower than
58% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.26 vs. CVS: 16.81 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 22.42
CVS's PE(NRI) is ranked higher than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 22.35 vs. CVS: 22.42 )
Ranked among companies with meaningful PE(NRI) only.
CVS' s PE(NRI) Range Over the Past 10 Years
Min: 10.62  Med: 18.43 Max: 27.17
Current: 22.42
10.62
27.17
Price/Owner Earnings (ttm) 15.55
CVS's Price/Owner Earnings (ttm) is ranked higher than
53% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.50 vs. CVS: 15.55 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
CVS' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 9.33  Med: 20.97 Max: 60.4
Current: 15.55
9.33
60.4
P/B 2.97
CVS's P/B is ranked lower than
64% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.55 vs. CVS: 2.97 )
Ranked among companies with meaningful P/B only.
CVS' s P/B Range Over the Past 10 Years
Min: 1.01  Med: 1.78 Max: 3.37
Current: 2.97
1.01
3.37
P/S 0.64
CVS's P/S is ranked lower than
58% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.49 vs. CVS: 0.64 )
Ranked among companies with meaningful P/S only.
CVS' s P/S Range Over the Past 10 Years
Min: 0.4  Med: 0.62 Max: 0.89
Current: 0.64
0.4
0.89
PFCF 15.67
CVS's PFCF is ranked lower than
63% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.25 vs. CVS: 15.67 )
Ranked among companies with meaningful PFCF only.
CVS' s PFCF Range Over the Past 10 Years
Min: 9.12  Med: 21.75 Max: 211.81
Current: 15.67
9.12
211.81
POCF 11.46
CVS's POCF is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.23 vs. CVS: 11.46 )
Ranked among companies with meaningful POCF only.
CVS' s POCF Range Over the Past 10 Years
Min: 6.72  Med: 13.26 Max: 23.92
Current: 11.46
6.72
23.92
EV-to-EBIT 14.46
CVS's EV-to-EBIT is ranked lower than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.10 vs. CVS: 14.46 )
Ranked among companies with meaningful EV-to-EBIT only.
CVS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.6  Med: 11.7 Max: 20.4
Current: 14.46
7.6
20.4
EV-to-EBITDA 11.46
CVS's EV-to-EBITDA is ranked lower than
64% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.33 vs. CVS: 11.46 )
Ranked among companies with meaningful EV-to-EBITDA only.
CVS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 9.5 Max: 16
Current: 11.46
6.2
16
PEG 1.64
CVS's PEG is ranked lower than
57% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.48 vs. CVS: 1.64 )
Ranked among companies with meaningful PEG only.
CVS' s PEG Range Over the Past 10 Years
Min: 0.56  Med: 1.45 Max: 2.48
Current: 1.64
0.56
2.48
Shiller P/E 30.77
CVS's Shiller P/E is ranked lower than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.39 vs. CVS: 30.77 )
Ranked among companies with meaningful Shiller P/E only.
CVS' s Shiller P/E Range Over the Past 10 Years
Min: 17.19  Med: 26.41 Max: 39.05
Current: 30.77
17.19
39.05
Current Ratio 1.11
CVS's Current Ratio is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.39 vs. CVS: 1.11 )
Ranked among companies with meaningful Current Ratio only.
CVS' s Current Ratio Range Over the Past 10 Years
Min: 1.05  Med: 1.51 Max: 2.09
Current: 1.11
1.05
2.09
Quick Ratio 0.57
CVS's Quick Ratio is ranked lower than
90% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. CVS: 0.57 )
Ranked among companies with meaningful Quick Ratio only.
CVS' s Quick Ratio Range Over the Past 10 Years
Min: 0.29  Med: 0.58 Max: 0.93
Current: 0.57
0.29
0.93
Days Inventory 35.58
CVS's Days Inventory is ranked lower than
89% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.05 vs. CVS: 35.58 )
Ranked among companies with meaningful Days Inventory only.
CVS' s Days Inventory Range Over the Past 10 Years
Min: 35.58  Med: 44.51 Max: 72.98
Current: 35.58
35.58
72.98
Days Sales Outstanding 28.86
CVS's Days Sales Outstanding is ranked higher than
55% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 30.61 vs. CVS: 28.86 )
Ranked among companies with meaningful Days Sales Outstanding only.
CVS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.77  Med: 21.26 Max: 28.86
Current: 28.86
18.77
28.86
Days Payable 19.30
CVS's Days Payable is ranked lower than
73% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 55.99 vs. CVS: 19.30 )
Ranked among companies with meaningful Days Payable only.
CVS' s Days Payable Range Over the Past 10 Years
Min: 16.69  Med: 19.86 Max: 28.69
Current: 19.3
16.69
28.69

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.66
CVS's Dividend Yield is ranked higher than
59% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. CVS: 1.66 )
Ranked among companies with meaningful Dividend Yield only.
CVS' s Dividend Yield Range Over the Past 10 Years
Min: 0.42  Med: 1.1 Max: 1.68
Current: 1.66
0.42
1.68
Dividend Payout 0.36
CVS's Dividend Payout is ranked lower than
57% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.29 vs. CVS: 0.36 )
Ranked among companies with meaningful Dividend Payout only.
CVS' s Dividend Payout Range Over the Past 10 Years
Min: 0.08  Med: 0.15 Max: 1.4
Current: 0.36
0.08
1.4
Dividend Growth (3y) 29.10
CVS's Dividend Growth (3y) is ranked higher than
62% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.60 vs. CVS: 29.10 )
Ranked among companies with meaningful Dividend Growth (3y) only.
CVS' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -13.6  Med: 15.2 Max: 37
Current: 29.1
-13.6
37
Forward Dividend Yield 1.75
CVS's Forward Dividend Yield is ranked higher than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.76 vs. CVS: 1.75 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 6.55
CVS's Yield on cost (5-Year) is ranked higher than
62% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.65 vs. CVS: 6.55 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CVS' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.66  Med: 4.34 Max: 6.63
Current: 6.55
1.66
6.63
3-Year Average Share Buyback Ratio 3.70
CVS's 3-Year Average Share Buyback Ratio is ranked higher than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.20 vs. CVS: 3.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CVS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -22.5  Med: -0.3 Max: 4.7
Current: 3.7
-22.5
4.7

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.04
CVS's Price/Projected FCF is ranked higher than
65% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.09 vs. CVS: 1.04 )
Ranked among companies with meaningful Price/Projected FCF only.
CVS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.82  Med: 1.98 Max: 13.38
Current: 1.04
0.82
13.38
Price/DCF (Earnings Based) 1.38
CVS's Price/DCF (Earnings Based) is ranked lower than
56% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.21 vs. CVS: 1.38 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.04
CVS's Price/Median PS Value is ranked lower than
54% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. CVS: 1.04 )
Ranked among companies with meaningful Price/Median PS Value only.
CVS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.5  Med: 1 Max: 2.35
Current: 1.04
0.5
2.35
Price/Peter Lynch Fair Value 1.58
CVS's Price/Peter Lynch Fair Value is ranked lower than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.18 vs. CVS: 1.58 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CVS' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.63  Med: 1.56 Max: 6.09
Current: 1.58
0.63
6.09
Earnings Yield (Greenblatt) (%) 6.87
CVS's Earnings Yield (Greenblatt) (%) is ranked higher than
50% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.90 vs. CVS: 6.87 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CVS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.9  Med: 8.6 Max: 13.2
Current: 6.87
4.9
13.2
Forward Rate of Return (Yacktman) (%) 18.38
CVS's Forward Rate of Return (Yacktman) (%) is ranked higher than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.38 vs. CVS: 18.38 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CVS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9.5  Med: 16.3 Max: 24.2
Current: 18.38
9.5
24.2

More Statistics

Revenue (TTM) (Mil) $166,730
EPS (TTM) $ 4.35
Beta0.88
Short Percentage of Float1.04%
52-Week Range $81.37 - 106.67
Shares Outstanding (Mil)1,074.02

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 180,089 194,440 202,498
EPS ($) 5.64 6.49 7.23
EPS w/o NRI ($) 5.64 6.49 7.23
EPS Growth Rate
(3Y to 5Y Estimate)
14.15%
Dividends Per Share ($) 1.55 1.70 2.35
» More Articles for CVS

Headlines

Articles On GuruFocus.com
Target Slashes Outlook Aug 17 2016 
Stocks Lower with Flat Retail Sales Report Aug 12 2016 
Ray Dalio's 5 Biggest 2nd-Quarter New Stock Buys Aug 11 2016 
Ray Dalio's 5 Biggest 2nd-Quarter New Stock Buys Aug 11 2016 
Jeff Auxier's Summer 2016 Market Commentary Aug 05 2016 
Jerome Dodson Goes 3 for 3 in Second Quarter Jul 21 2016 
CVS and Walgreens: A Duopoly That's Hard to Ignore Jul 08 2016 
Stocks Manning & Napier Continues Buying Jun 14 2016 
Pioneer Investments Adds to Stake in CVS May 12 2016 
High Quality Guru Stocks Include TransDigm, Chipotle May 03 2016 

More From Other Websites
Top trades for the 2nd half: CVS, SQ & more Aug 23 2016
Did Target’s Fiscal 2Q16 Same-Store Sales Growth Meet Guidance? Aug 23 2016
CVS Health Research Institute Study Shows Value in Tailoring Medication Adherence Interventions to... Aug 22 2016
AAPL, CVS, URBN: Jim Cramer's Views Aug 22 2016
Moody's Upgrades One, Affirms One, and Downgrades One Class of FUNCM 1999-C2 Aug 19 2016
RenTech Loaded Up On Mastercard, Nike, More in Q2 Aug 18 2016
CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy... Aug 18 2016
CVS Health and the CVS Health Foundation Announce $100K Donation In Support of Louisiana Flood... Aug 18 2016
Why Selling Drugs Has Gotten Tougher for Target Aug 18 2016
Cramer: Target's Excuses Really Don't Cut It Aug 17 2016
Target Slashes Profit Guidance Amid Weak Apple Sales Aug 17 2016
Target cuts outlook as it sees fewer customers in stores Aug 17 2016
Target cuts outlook as it sees fewer customers in stores Aug 17 2016
Target: Prudent…But Painful Aug 17 2016
Target Blames Apple, Two Other Things for Weak Sales Aug 17 2016
CVS Health Survey Reveals Two in Five Americans Make Multiple Trips to get Entire Household... Aug 17 2016
CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy... Aug 17 2016
Can Target Withstand Amazon’s Wrath? Aug 16 2016
5 Stocks to Watch Before the Market Opens Tomorrow Aug 16 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)